334 related articles for article (PubMed ID: 29173789)
21. The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia.
Alfayez OM; Alsallum AA; Aljabri AF; Almutairi FS; Al-Azzeh O; Almalki OS; Al Yami MS; Almohammed OA
Front Public Health; 2022; 10():989072. PubMed ID: 36159298
[TBL] [Abstract][Full Text] [Related]
22. Drug therapy in prediabetes.
Mukhopadhyay P; Chowdhury S
J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US.
Shealy KM; Wu J; Waites J; Taylor NA; Blair Sarbacker G
J Am Board Fam Med; 2019; 32(2):209-217. PubMed ID: 30850457
[TBL] [Abstract][Full Text] [Related]
24. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
Goldberg RB; Mather K
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
Smith-Marsh D
Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
[TBL] [Abstract][Full Text] [Related]
26. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
27. Metformin as a weight-loss tool in "at-risk" obese adolescents: a magic bullet?
Kasa-Vubu JZ
J Pediatr; 2008 Jun; 152(6):750-2. PubMed ID: 18492507
[No Abstract] [Full Text] [Related]
28. Addressing prediabetes in childhood obesity treatment programs: support from research and current practice.
Haemer MA; Grow HM; Fernandez C; Lukasiewicz GJ; Rhodes ET; Shaffer LA; Sweeney B; Woolford SJ; Estrada E
Child Obes; 2014 Aug; 10(4):292-303. PubMed ID: 25055134
[TBL] [Abstract][Full Text] [Related]
29. More effective glycaemic control by metformin in African Americans than in Whites in the prediabetic population.
Zhang C; Zhang R
Diabetes Metab; 2015 Apr; 41(2):173-5. PubMed ID: 25659998
[TBL] [Abstract][Full Text] [Related]
30. Metformin in obese children and adolescents: the MOCA trial.
Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
[TBL] [Abstract][Full Text] [Related]
31. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study.
Moin T; Li J; Duru OK; Ettner S; Turk N; Keckhafer A; Ho S; Mangione CM
Ann Intern Med; 2015 Apr; 162(8):542-8. PubMed ID: 25894024
[TBL] [Abstract][Full Text] [Related]
32. Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012.
Rodriguez-Gutierrez R; Montori VM
Ann Intern Med; 2015 Sep; 163(6):482-3. PubMed ID: 26370016
[No Abstract] [Full Text] [Related]
33. METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.
van der Aa MP; Elst MA; van Mil EG; Knibbe CA; van der Vorst MM
Trials; 2014 Jun; 15():207. PubMed ID: 24899137
[TBL] [Abstract][Full Text] [Related]
34. Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
Chukir T; Mandel L; Tchang BG; Al-Mulla NA; Igel LI; Kumar RB; Waitman J; Aronne LJ; Shukla AP
Obes Res Clin Pract; 2021; 15(1):64-68. PubMed ID: 33386253
[TBL] [Abstract][Full Text] [Related]
35. Prescribing Patterns of Metformin in High-risk Patients with Prediabetes.
Stirling DL; Onor I; Sarpong D; Rapp KI; Crawford LD
J La State Med Soc; 2015; 167(6):257-62. PubMed ID: 26741685
[TBL] [Abstract][Full Text] [Related]
36. (5) Prevention or delay of type 2 diabetes.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S31-2. PubMed ID: 25537704
[No Abstract] [Full Text] [Related]
37. Review of Metformin Use for Type 2 Diabetes Prevention.
Moin T; Schmittdiel JA; Flory JH; Yeh J; Karter AJ; Kruge LE; Schillinger D; Mangione CM; Herman WH; Walker EA
Am J Prev Med; 2018 Oct; 55(4):565-574. PubMed ID: 30126667
[TBL] [Abstract][Full Text] [Related]
38. Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012.
Moin T; Duru OK; Mangione CM
Ann Intern Med; 2015 Sep; 163(6):483. PubMed ID: 26370017
[No Abstract] [Full Text] [Related]
39. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
40. Choice of Intensive Lifestyle Change and/or Metformin after Shared Decision Making for Diabetes Prevention: Results from the Prediabetes Informed Decisions and Education (PRIDE) Study.
Moin T; Martin JM; Mangione CM; Grotts J; Turk N; Norris KC; Tseng CH; Jeffers KS; Castellon-Lopez Y; Frosch DL; Duru OK
Med Decis Making; 2021 Jul; 41(5):607-613. PubMed ID: 33813948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
